Aggressive Hydration with Lactated Ringer Solution in Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis: a randomized, controlled clinical trial.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

TCTR

Registry ID

TCTR20180209002

Enrollment

148

Registered

2018-02-09

Start date

2018-03-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post ERCP pancreatitis Pancreatitis&#44

Interventions

LRS intravenous 3 mL/kg/hr during ERCP then LRS intravenous 20 mL/kg/hr immediately after ERCP then LRS 3 mL/kg/hr intravenous until 8 hr post ERCP ,LRS intravenous 1.5 mL/kg/hr during ERCP and con

Experimental Drug,Sham Comparator Drug

Aggressive Hydration with Lactated Ringer Solution ,Standard Hydration with Lactated Ringer Solution

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients who have indicated for ERCP

Exclusion criteria

Exclusion criteria: Severe co-morbid diseases (eg, cardiac disease, pulmonary disease, renal disease, endocrine disease) Pregnancy

Design outcomes

Primary

Measure	Time frame
Post ERCP pancreatitis Within 24 hours after ERCP Incidence	—

Secondary

Measure	Time frame
Spatio-temporal parameters One day Orthotrak software version 6.6 ,Ground reaction force One day Orthotrak software version 6.6	—

Countries

Thailand

Contacts

Public ContactApichet Sirinawasatien

Rajavithi Hospital

sui_apichet@hotmail.com081-6862151

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

Aggressive Hydration with Lactated Ringer Solution in Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis: a randomized&#44; controlled clinical trial.